Wexford Capital’s Organon & Co OGN Stock Holding History

Wexford Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,947	Closed	-$100K	–	321
2025 Q4	$100K	Buy	+13,947	New	+$110K	0.02%	245

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Wexford Capital's OGN Position: Q1 2026 in Review

Wexford Capital sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 13,947 shares — an estimated $100K sold.

Wexford Capital first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $100K in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Wexford Capital reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
Wexford Capital sold 13,947 Organon & Co shares in Q1 2026, an estimated $100K.
Wexford Capital first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
Wexford Capital's Organon & Co position peaked at $100K in Q4 2025.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Wexford Capital's 13F filing for Q1 2026, filed 15 May 2026.